Earnings History Data for Adaptimmune Therapeutics plc (ADAP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12-08-2024 | PM | ADAP | Adaptimmune Therapeutics plc | 252.24 | 0.27 | 0.00 | -0.21 | Adaptimmune GAAP EPS of $0.05 beats by $0.05, revenue of $128.2M beats by $83.44M [8/12/2024 7:09 AM] |
1.08 | 0.09 (8.95%) |
1.10 | 0.11 (10.79%) |
0.42 - 2.05 | 3,868,265 | 3,510,000 | 434,284 | ||
15-05-2024 | PM | ADAP | Adaptimmune Therapeutics plc | 276.44 | -0.18 | -0.16 | 0.01 | Adaptimmune GAAP EPS of -$0.03 beats by $0.04, revenue of $5.7M misses by $11.37M [5/15/2024 7:45 AM] |
1.21 | 0.06 (5.22%) |
1.18 | 0.03 (2.61%) |
0.42 - 2.05 | 1,318,569 | 780,000 | 67,402 | ||
06-03-2024 | PM | ADAP | Adaptimmune Therapeutics | 1,471 | -0.24 | -0.12 | 0.00 | 1.72 | 0.26 (17.81%) |
1.55 | 0.09 (6.16%) |
0.42 - 1.79 | 2,059,832 | 1,560,000 | 116,068 | |||
08-11-2023 | PM | ADAP | Adaptimmune Therapeutics plc | 132.81 | -0.20 | -0.20 | -0.24 | Adaptimmune GAAP EPS of -$0.03 beats by $0.16, revenue of $7.3M misses by $7.84M [11/8/2023 7:37 AM] |
0.5682 | -0.03 (-4.66%) |
0.57 | -0.03 (-4.33%) |
0.52 - 2.65 | 205,371 | 300,000 | 31,792 | ||
09-08-2023 | PM | ADAP | Adaptimmune Therapeutics plc | 142.50 | -0.21 | -0.17 | -0.28 | Adaptimmune GAAP EPS of -$0.02 beats by $0.19, revenue of $5.13M misses by $1.54M [8/9/2023 7:56 AM] |
0.85 | -0.01 (-1.16%) |
0.0 | 0.0 (0.00%) |
0.84 - 2.65 | 476,904 | 490,000 | 0 | ||
12-05-2023 | PM | 0:00 AM ET (May 12) |
ADAP | Adaptimmune Therapeutics | 217.00 | 0.01 | -0.19 | 0.00 | Adaptimmune GAAP EPS of $0.00 beats by $0.14, revenue of $47.6M [5/12/2023 8:39 AM] |
1.37 | 0.01 (0.74%) |
1.42 | 0.06 (4.41%) |
1.01 - 2.65 | 396,651 | 590,000 | 3,845 | |
06-03-2023 | PM | 0:00 AM ET (Mar 6) |
ADAP | Adaptimmune Therapeutics plc | 265.40 | -0.18 | -0.25 | -0.25 | Adaptimmune GAAP EPS of -$0.03 beats by $0.20, revenue of $11.03M beats by $5.95M [3/6/2023 6:44 AM] |
1.33 | -0.43 (-24.43%) |
1.38 | -0.38 (-21.59%) |
1.01 - 2.65 | 4,315,111 | 180,000 | 435,241 | |
|
||||||||||||||||||
08-11-2022 | PM | ADAP | Adaptimmune Therapeutics plc | 259.76 | -0.24 | -0.28 | -0.27 | Adaptimmune GAAP EPS of -$0.04 beats by $0.22, revenue of $7M beats by $2.03M [11/8/2022 8:33 AM] |
2.09 | 0.43 (25.90%) |
1.80 | 0.14 (8.43%) |
1.01 - 5.95 | 1,409,268 | 360,000 | 11,223 | ||
|
||||||||||||||||||
04-08-2022 | PM | 7:30 AM ET (Aug 4) |
ADAP | Adaptimmune Therapeutics plc | 294.87 | -0.28 | -0.28 | -0.24 | Adaptimmune Non-GAAP EPS of -$0.05 beats by $0.24, revenue of $5.54M misses by $3.16M [8/4/2022 7:35 AM] |
2.31 | 0.37 (19.07%) |
3.92 | -0.40 (-9.26%) |
1.26 - 6.86 | 496,636 | 180,000 | 51,552 | |
09-05-2022 | PM | 8:00 AM ET (May 9) |
ADAP | Adaptimmune Therapeutics plc | 279.22 | -0.32 | -0.26 | -0.24 | Adaptimmune GAAP EPS of -$0.05 beats by $0.19, revenue of $3.6M misses by $1.4M [5/9/2022 7:32 AM] |
1.55 | -0.16 (-9.36%) |
1.71 | 0.0 (0.00%) |
1.50 - 6.86 | 787,004 | 910,000 | 407 | |
14-03-2022 | PM | 7:30 AM ET (Mar 14) |
ADAP | Adaptimmune Therapeutics plc | 295.23 | -0.25 | -0.22 | -0.24 | Adaptimmune GAAP EPS of -$0.04, revenue of $1.4M [3/14/2022 8:05 AM] |
1.82 | 0.0 (0.00%) |
1.85 | 0.03 (1.65%) |
1.77 - 6.86 | 1,034,086 | 1,000,535 | 4,760 | |
04-11-2021 | PM | 7:30 AM ET (Nov 4) |
ADAP | Adaptimmune Therapeutics plc | 841.32 | -0.27 | 0.05 | -0.23 | Adaptimmune EPS beats by $0.21, beats on revenue [11/4/2021 7:34 AM] |
5.25 | -0.22 (-4.02%) |
5.25 | 0.0 (0.00%) |
3.37 - 7.34 | 420,698 | 470,000 | 206 | |
|
||||||||||||||||||
09-08-2021 | AH | After the close (Aug 9) |
ADAP | Adaptimmune Therapeutics plc | 548.91 | -0.24 | -0.25 | -0.24 | Adaptimmune EPS beats by $0.20, beats on revenue [8/9/2021 4:05 PM] |
3.57 | 0.12 (3.33%) |
3.65 | 0.20 (5.80%) |
3.37 - 10.93 | 1,327,051 | 420,000 | 32,419 | |
|
||||||||||||||||||
06-05-2021 | PM | 7:30 AM ET (May 6) |
ADAP | Adaptimmune Therapeutics plc | 831.82 | -0.24 | -0.25 | -0.24 | Adaptimmune EPS beats by $0.21, misses on revenue [5/6/2021 7:32 AM] |
4.90 | -0.22 (-4.30%) |
4.90 | 0.0 (0.00%) |
3.36 - 13.40 | 1,144,335 | 830,000 | 950 | |
25-02-2021 | PM | 7:30 AM ET (Feb 25) |
ADAP | Adaptimmune Therapeutics plc | 920.93 | -0.24 | -0.23 | -0.28 | Adaptimmune EPS beats by $0.19, beats on revenue [2/25/2021 7:32 AM] |
5.97 | -0.02 (-0.33%) |
6.02 | 0.03 (0.50%) |
2.00 - 13.40 | 535,627 | 1,182,365 | 1,548 | |
05-11-2020 | PM | 7:30 AM ET (Nov 5) |
ADAP | Adaptimmune Therapeutics plc | 808.62 | -0.23 | -0.23 | -0.37 | Adaptimmune EPS beats by $0.19, beats on revenue [11/5/2020 7:36 AM] |
5.31 | 0.01 (0.19%) |
5.31 | 0.0 (0.00%) |
0.71 - 13.40 | 1,130,047 | 2,352,031 | 3,101 | |
|
||||||||||||||||||
06-08-2020 | PM | 7:30 AM ET (Aug 6) |
ADAP | Adaptimmune Therapeutics plc | 1,390 | -0.24 | -0.24 | -0.42 | Adaptimmune EPS beats by $0.20, misses on revenue [8/6/2020 7:34 AM] |
8.50 | -0.22 (-2.52%) |
8.70 | -0.02 (-0.23%) |
0.71 - 13.40 | 410,014 | 667,680 | 6,947 | |
|
||||||||||||||||||
14-05-2020 | PM | 7:30 AM ET (May 14) |
ADAP | Adaptimmune Therapeutics plc | 641.39 | -0.24 | -0.13 | -0.24 | Adaptimmune EPS beats by $0.21, misses on revenue [5/14/2020 7:37 AM] |
4.35 | -0.19 (-4.18%) |
4.65 | 0.11 (2.42%) |
0.71 - 6.00 | 789,373 | 1,077,558 | 16,917 | |
|